Skip to main content
. 2010 Oct 29;7:72. doi: 10.1186/1742-2094-7-72

Figure 3.

Figure 3

Plasma CML and CEL levels in DMT-naïve MS patients at various disease stages. Plasma CML (A) and CEL (B) at various disease stages, in DMT-naïve, clinically stable MS patients. Results are means ± SEM for 4 CIS patients, 28 RRMS patients, 8 SPMS patients and 7 PPMS patients. Abbreviations as in Table 1.